Drug resistance-conferring protein, antibodies reactive...

Details Drug resistance-conferring protein, antibodies reactive... Drug resistance-conferring protein, antibodies reactive...

C - Chemistry, Metallurgy

12

P

C12P 21/08 (2006.01) A61K 39/395 (2006.01) C07K 16/18 (2006.01) G01N 33/566 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) G01N 33/94 (2006.01)

Patent

CA 2102256

Abstract Monoclonal and genetically engineered antibodies which react with P190, a protein associated with anthracycline resistance are disclosed. The P190 reactive antibodies are useful in determining anthracycline resistance and purification of P190. P190 and antibodies reactive therewith are useful for screening P190 antagonists.

Affiliated with

Also associated with

Rating

Drug resistance-conferring protein, antibodies reactive... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug resistance-conferring protein, antibodies reactive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug resistance-conferring protein, antibodies reactive... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2074486